Abstract:Abstract A well-established preclinical model of pancreatic cancer needs to be established to facilitate research on new therapeutic targets. Recently established animal models of pancreatic cancer, including patient-derived tumor models and organoid models, are used for pre-clinical drug testing and biomarker discovery. These models have useful characteristics over conventional xenograft mouse models based on cell lines in preclinical studies, but still cannot accurately predict the clinical outcomes of new treatments and have not yet been broadly implemented in research. We employed pancreatic cancer organoid culture methods using the pancreatic cancer cell line S2-013, and performed pathological and immunohistochemical analyses to characterize tumor xenografts obtained from a mouse model implanted with S2-013 cell line-derived organoids. Serum levels of the pancreatic cancer tumor marker CA19-9 were measured by ELISA. We generated human pancreatic cancer organoids using a co-culture of S2-013 cells, human endothelial cells derived from human umbilical vein endothelial cells, and human mesenchymal stem cells, and established a mouse model with subcutaneously transplanted human pancreatic cancer organoids (S2-013-organoid model). Although blood clotting crater-like formation developed in the middle of subcutaneous xenografts in the S2-013-conventional model, created by subcutaneously injecting S2-013 cells into the right flank of nude mice, the size of xenografts in the S2-013-organoid model gradually increased without crater-like formation. Importantly, tumor xenografts obtained from the S2-013-organoid model exhibited a clinical human pancreatic cancer tissue-like cellular morphology, tissue architecture, and polarity, and actively formed cancer stroma containing mature blood vessels with the high expression of the vascular tight junction marker CD31. In subcutaneous xenografts of S2-013-conventional mice, no blood vessel density or widely expanding areas of necrotic regions were present. Consequently, serum levels of CA19-9 in the S2-013-organoid model correlated with tumor volumes. In addition, epithelial–mesenchymal transition, the conversion of epithelial cells to the mesenchymal phenotype, was observed in tumor xenografts of the S2-013-organoid model. The S2-013-organoid model provides tumor xenografts consisting of clinical human pancreatic cancer-like tissue formation with the effective development of vascularized stroma, and may be valuable for facilitating studies on pre-clinical drug testing and biomarker discovery.

Establishment of an Animal Model of Human Cavernous Angioma for Drug Screening

Abstract WP346: A Cost-effective and Reproducible Mouse Model of Intracranial Aneurysm: Renal Hypertension and Local Hemodynamic Change Combined with Elastase Infusion

A Preliminary Study of Murine Hemangioma Model by Delivery of Recombinant Adeno-Associated Virus Mediated Human Vascular Endothelial Growth Factor-121 Gene

Morphological Observation And In Vitro Angiogenesis Assay Of Endothelial Cells Isolated From Human Cerebral Cavernous Malformations

Human microvascular endothelial cells immortalized with human telomerase catalytic protein: a model for the study of in vitro angiogenesis.

In Vitro Characterization of the Angiogenic Phenotype and Genotype of the Endothelia Derived from Sporadic Cerebral Cavernous Malformations

Development of an angiogenesis animal model featuring brain arteriovenous malformation histological characteristics

Perfusable Vessel-on-a-Chip for Antiangiogenic Drug Screening with Coaxial Bioprinting

Effects of Vascular Endothelial Growth Factor on Angiogenesis of the Endothelial Cells Isolated from Cavernous Malformations

An assay for cancer stem cell-induced angiogenesis on chick chorioallantoic membrane

Construction of Human Liver Cancer Vascular Endothelium Cdna Expression Library and Screening of the Endothelium-Associated Antigen Genes

A Novel Xenograft Model In Zebrafish For High-Resolution Investigating Dynamics Of Neovascularization In Tumors

An ex-vivo angiogenesis assay as a screening method for natural compounds and herbal drug preparations

Systematic assessment in an animal model of the angiogenic potential of different human cell sources for therapeutic revascularization

Three-Dimensional Microtumor Formation of Infantile Hemangioma-Derived Endothelial Cells for Mechanistic Exploration and Drug Screening

Establishment and characterization of a novel in vitro angiogenesis model using a microvascular endothelial cell line, F-2C, cultured in chemically defined medium

Isolation and Identification of Vascular Endothelial Cells from Hepatocellular Carcinoma Xenografts in Nude Mice

Establishment of a mouse model of pancreatic cancer using human pancreatic cancer cell line S2-013-derived organoid

Establishment of a visualized mouse orthotopic model of nasopharyngeal carcinoma.

The establishment of animal model with coronary microembolization suitable for long-term observation by using endovascular microcatheter technique

Screening for an Animal Model of Human Lung Cancer with Highly Metastatic Potential As Well As Establishment Its Correspording Cell Line